Taysha Gene Therapies

-$0.21 (-7.05%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.

About TSHA

Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing.

CEO
R. A. Session
Employees
—
Headquarters
Dallas, Texas
Founded
2019

TSHA Key Statistics

Market cap
112.11M
Price-Earnings ratio
—
Dividend yield
—
Average volume
277.13K
High today
$3.05
Low today
$2.62
Open price
$3.04
Volume
360.09K
52 Week high
$26.99
52 Week low
$2.62

TSHA Earnings

-$1.35
-$0.90
-$0.45
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$1.07 per share
Actual
-$1.31 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure